EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische Übersicht

Aging Biomarkers in Osteoporosis: A Systematic Review of Molecular Mechanisms, Biological Aging, and Population Evidence

Miaosen Liu, Su Yon Jung

aging and disease · 2026

DOI: 10.14336/ad.2025.1653 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift aging and disease, 2026. Verfasst von Miaosen Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While chronological age is an important risk factor for osteoporosis, biological aging measures may better capture nuances in systemic and bone-tissue aging among same-age individuals. This review aims to summarize the associations between DNA methylation/telomere dysfunction (mainly telomere shortening) and bone health. We searched for human epidemiological studies that examined the associations between blood-based epigenetic aging clocks or leukocyte telomere length (LTL) and osteoporosis-related outcomes on PubMed and Embase. Five epigenetic aging-related studies and 14 LTL-related studies were eventually included, from which data on study design, population, bone health-related outcomes, and statistically significant effect estimates were extracted. Risk of bias was assessed using the Newcastle-Ottawa Scale for observational studies. Findings were summarized narratively due to heterogeneity in study design, biomarkers, and outcome definitions. This review concludes that while laboratory-based studies often provide evidence of aging biomarkers’ association with bone outcomes, population-level epidemiological studies provide inconclusive evidence, highlighting limited studies on epigenetic aging clocks and bone health, and inconsistent findings regarding the association between LTL and bone health. Challenges many of the human studies faced include small sample sizes, inadequate study designs, non-diverse cohorts, and heterogeneity in epigenetic clock selection and/or bone health outcomes. Future research should focus on conducting prospective studies with larger, independent cohort sizes and comprehensive adjustment for intervening factors to paint a clearer picture of the biological aging markers’ associations with osteoporosis and provide guidance on their potential clinical relevance in bone health.

Autor:innen und Institutionen

  • Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Translational Sciences Section, School of Nursing, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Zitieren

APA

Liu, M., & Jung, S. Y. (2026). Aging Biomarkers in Osteoporosis: A Systematic Review of Molecular Mechanisms, Biological Aging, and Population Evidence. aging and disease. https://doi.org/10.14336/ad.2025.1653

Vancouver

Liu M, Jung SY. Aging Biomarkers in Osteoporosis: A Systematic Review of Molecular Mechanisms, Biological Aging, and Population Evidence. aging and disease. 2026. doi:10.14336/ad.2025.1653

BibTeX
@article{Liu2026,
  author = {Liu, Miaosen and Jung, Su Yon},
  title = {Aging Biomarkers in Osteoporosis: A Systematic Review of Molecular Mechanisms, Biological Aging, and Population Evidence},
  journal = {aging and disease},
  year = {2026},
  doi = {10.14336/ad.2025.1653}
}
Kostenlos starten →